Randomized clinical trial of tranexamic acid-free fibrin sealant during vascular surgical procedures

British Journal of Surgery

Volumn 97, Issue 12, 2010, Pages 1784-1789

  Chalmers, R T A ^a   Darling III, R C ^c   Wingard, J T ^d   Chetter, I ^b   Cutler, B ^e   Kern, J A ^f   Hart, J C ^g  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b HULL ROYAL INFIRMARY   (United Kingdom)

^c ALBANY MEDICAL CENTER   (United States)

^d Memorial Hospital Jacksonville   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g ETHICON INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN GLUE; HEMOSTATIC AGENT; TRANEXAMIC ACID;

ADULT; AGED; ANASTOMOSIS; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; COMPRESSION BANDAGE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEMOSTASIS; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UNITED KINGDOM; UNITED STATES; VASCULAR SURGERY;

ADULT; AGED; AGED, 80 AND OVER; ANASTOMOSIS, SURGICAL; COMPRESSION BANDAGES; FEMALE; FIBRIN TISSUE ADHESIVE; GREAT BRITAIN; HEMOSTASIS, SURGICAL; HEMOSTATICS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TRANEXAMIC ACID; TREATMENT OUTCOME; UNITED STATES; VASCULAR SURGICAL PROCEDURES;

EID: 78449312811     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7235     Document Type: Article

References (16)

1. Atkinson JB, Gomperts ED, Kang R, Lee M, Arensman RM, Bartlett RH, et al., Prospective, randomized evaluation of the efficacy of fibrin sealant as a topical hemostatic agent at the cannulation site in neonates undergoing extracorporeal membrane oxygenation. Am J Surg 1997; 173: 479-484.
2. Frilling A, Stavrou GA, Mischinger HJ, de Hemptinne B, Rokkjaer M, Klempnauer J, et al., Effectiveness of a new carrier-bound fibrin sealant versus argon beamer as haemostatic agent during liver resection: a randomised prospective trial. Langenbecks Arch Surg 2005; 390: 114-120.
3. Schwartz M, Madariaga J, Hirose R, Shaver TR, Sher L, Chari R, et al., Comparison of a new fibrin sealant with standard topical hemostatic agents. Arch Surg 2004; 139: 1148-1154.
4. Wang GJ, Hungerford DS, Savory CG, Rosenberg AG, Mont MA, Burks SG, et al., Use of fibrin sealant to reduce bloody drainage and hemoglobin loss after total knee arthroplasty: a brief note on a randomized prospective trial. J Bone Joint Surg Am 2001; 83-A: 1503-1505.
5. Martin K, Wiesner G, Breuer T, Lange R, Tassani P,. The risks of aprotinin and tranexamic acid in cardiac surgery: a one-year follow-up of 1188 consecutive patients. Anesth Analg 2008; 107: 1783-1790.
6. Murkin JM, Falter F, Granton J, Young B, Burt C, Chu M,. High-dose tranexamic acid is associated with nonischemic clinical seizures in cardiac surgical patients. Anesth Analg 2010; 110: 350-353.
7. Scheule AM, Beierlein W, Wendel HP, Eckstein FS, Heinemann MK, Ziemer G,. Fibrin sealant, aprotinin, and immune response in children undergoing operations for congenital heart disease. J Thorac Cardiovasc Surg 1998; 115: 883-889. (Pubitemid 28196600)
8. Nur I, Bar L, Meidler R, Gorman A,. Plasminogen free fibrin sealant. Transactions of the Society For Biomaterials, Pittsburgh, 2006.
9. ICH Expert Working Group. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline. Guideline for Good Clinical Practice E6(R1). Current Step 4 version. 10 June1996. [accessed 27 July 2010].
10. World Medical Association. Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects. [accessed 27 July 2010].
11. Taylor LM Jr, Mueller-Velten G, Koslow A, Hunter G, Naslund T, Kline R, et al., Prospective randomized multicenter trial of fibrin sealant versus thrombin-soaked gelatin sponge for suture- or needle-hole bleeding from polytetrafluoroethylene femoral artery grafts. J Vasc Surg 2003; 38: 766-771.
12. Schenk WG III, Burks SG, Gagne PJ, Kagan SA, Lawson JH, Spotnitz WD,. Fibrin sealant improves hemostasis in peripheral vascular surgery: a randomized prospective trial. Ann Surg 2003; 237: 871-876.
13. Schlag MG, Hopf R, Redl H,. Convulsive seizures following subdural application of fibrin sealant containing tranexamic acid in a rat model. Neurosurgery 2000; 47: 1463-1467.
14. Beierlein W, Scheule AM, Antoniadis G, Braun C, Schosser R,. An immediate, allergic skin reaction to aprotinin after reexposure to fibrin sealant. Transfusion 2000; 40: 302-305.
15. Scheule AM, Beierlein W, Lorenz H, Ziemer G,. Repeated anaphylactic reactions to aprotinin in fibrin sealant. Gastrointest Endosc 1998; 48: 83-85.
16. Oswald AM, Joly LM, Gury C, Disdet M, Leduc V, Kanny G,. Fatal intraoperative anaphylaxis related to aprotinin after local application of fibrin glue. Anesthesiology 2003; 99: 762-763.